INTC · Intel CorpHold

Makes the processor chips that power computers and data center servers.

why The headlines do not explain a 316.8% rise for Intel; they mostly reference sector-wide semiconductor sell-offs and AI market volatility, not a specific catalyst driving Intel sharply higher.

Analysts are cautious and mostly sitting on the fence despite the massive run-up.

AMD · Advanced Micro Devices IncBuy

Designs chips for PCs, gaming consoles, and AI data centers.

why The headlines do not explain a 212.9% rise for AMD; coverage focuses on sector sell-offs, China AI competition fears, and an AI customer event, none of which account for a large sustained gain.

Analysts are strongly bullish and see more room to run.

GOOGL · Alphabet IncBuy

Runs the world's dominant search engine and a major cloud computing business.

why Alphabet's stock likely rose significantly driven by exceptional Google Cloud growth, with revenue up 63% last quarter, signaling strong AI-era momentum beyond its core advertising business. source

Analysts are overwhelmingly positive and view it as a top pick.

AAPL · Apple IncBuy

Makes iPhones, Macs, and runs a growing services business including the App Store.

why The headlines do not clearly explain Apple's 58.9% rise; coverage is largely general market commentary and a mention of an analyst resetting a price target, without a specific identifiable catalyst.

Analysts lean bullish and broadly back the long-term story.

JNJ · Johnson & JohnsonBuy

Develops and sells prescription medicines, medical devices, and consumer health products.

why The headlines do not clearly explain Johnson & Johnson's 55.3% rise; the sources reference general healthcare and market commentary but provide no specific JNJ catalyst.

Analysts are mostly positive and see steady upside ahead.

MRK · Merck & Co IncBuy

Researches and sells prescription drugs, most notably its blockbuster cancer immunotherapy.

why Merck's stock likely rose in part due to FDA approval of its cholesterol-lowering pill Lipfendra and continued oncology pipeline expansions, boosting investor confidence. source

Analysts are broadly bullish and favor its pipeline strength.

LLY · Eli Lilly and CoBuy

Makes prescription medicines including widely used diabetes and weight-loss drugs.

why Eli Lilly's stock surged driven by strong momentum in its GLP-1 weight-loss drug franchise, with headlines noting it could still win the market even as rivals launch oral alternatives, and a $3 billion deal reinforcing its pipeline strength. source

Analysts are very bullish and consider it a standout growth story in pharma.

UNH · UnitedHealth Group IncBuy

Provides health insurance coverage and healthcare services to millions of people.

why UnitedHealth Group's stock rose as the company raised its 2026 outlook, with analysts noting the stock still looked cheap even after gains, and investors shrugging off the loss of nearly one million Medicare members. source

Analysts are strongly positive and see it as a core healthcare holding.

ABBV · AbbVie IncBuy

Develops and sells specialty drugs, with a large immunology and oncology portfolio.

why AbbVie's stock likely rose partly on regulatory wins, including European Commission approval for its new rapid-onset neurotoxin Boey for treating frown lines, expanding its aesthetics portfolio. source

Analysts are broadly bullish and confident in its drug lineup.

AVGO · Broadcom IncBuy

Designs semiconductors and sells networking software used in data centers and broadband.

why The headlines do not clearly explain Broadcom's 29.5% rise; coverage focuses on general AI sector sell-offs and chip stock drawdowns rather than a specific positive catalyst for AVGO.

Analysts are very bullish and view it as a key AI infrastructure play.

COIN · Coinbase Global IncBuy

Operates one of the largest cryptocurrency trading platforms for retail and institutional customers.

why Coinbase stock likely fell due to bearish analyst sentiment, including JPMorgan slashing its price target, alongside broader crypto market concerns and intensifying stablecoin competition. source

Analysts still lean bullish overall but acknowledge the wild volatility is a real risk.

ORCL · Oracle CorpBuy

Sells database software and cloud services to businesses around the world.

why Oracle stock likely fell as prominent commentators including Jim Cramer turned bearish on the stock and Michael Burry expressed skepticism about ORCL, dampening investor sentiment. source

Analysts remain broadly positive on the cloud pivot despite the sharp selloff.

ADBE · Adobe IncHold

Makes creative and document software including Photoshop, Illustrator, and Acrobat.

why Adobe stock likely fell due to intensifying competition in the software space, with headlines highlighting a 'SaaSpocalypse' fear and competitive pressures from rivals including Figma, weighing on the stock. source

Analysts are largely on the fence, worried about AI competition eating into its moat.

CRM · Salesforce IncBuy

Provides cloud-based software that helps businesses manage customer relationships and sales.

why Salesforce stock likely fell as part of a broader software sector downturn, with headlines noting the stock seeing a more significant dip than the broader market amid general 'software stock wreckage.' source

Analysts are mostly bullish but the stock has struggled to find its footing.

MSFT · Microsoft CorpBuy

Sells Windows, Office, and Azure cloud services to consumers and enterprises globally.

why Microsoft stock likely fell on concerns that AI may have cannibalized its core narrative, with headlines questioning whether Microsoft's AI strategy is being undermined by competitors and internal pivots away from OpenAI. source

Analysts are strongly bullish and see the dip as a buying opportunity.

META · Meta Platforms IncBuy

Owns Facebook, Instagram, and WhatsApp, making money primarily through digital advertising.

why Meta stock saw only a modest decline despite heavy AI capital spending, as headlines show the company aggressively investing in AI infrastructure including its in-house Iris chip and a potential $10B deal with Anthropic, with markets weighing the large debt burden against growth prospects. source

Analysts are overwhelmingly positive and view any pullback as a chance to buy.

BRK.B · Berkshire Hathaway IncSell

Holds a large collection of wholly owned businesses and publicly traded stocks managed by Warren Buffett.

why Berkshire Hathaway posted modest gains, consistent with Warren Buffett's cautious stance and value-oriented approach, as headlines show Buffett urging caution in a market he described as favoring gambling over value. source

Analysts are actually leaning toward selling it here, an unusually bearish stance.

PFE · Pfizer IncHold

Discovers and sells prescription medicines and vaccines across a wide range of diseases.

why The available headlines do not directly explain Pfizer's modest 1-year gain; they reference dividends and general pharma sector news but provide no specific catalyst for Pfizer's price move.

Analysts are mostly neutral and waiting to see if the post-pandemic business can rebound.

QCOM · Qualcomm IncHold

Designs mobile processor chips and licenses wireless technology patents to phone makers.

why Qualcomm stock likely rose modestly due to securing long-term automotive supply deals to support AI vehicles, providing a growth catalyst beyond its core smartphone business. source

Analysts are largely neutral, uncertain about its longer-term smartphone and PC chip prospects.

NVDA · NVIDIA CorpBuy

Designs the high-powered graphics chips that have become the backbone of AI computing.

why The available headlines do not directly explain Nvidia's 17% gain over the past year; while one headline notes that buying chip stocks after a 20% drawdown has historically worked, no specific Nvidia catalyst is identified in the provided sources. source

Analysts are almost unanimously bullish and see it as the defining AI infrastructure stock.